Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Outlook on the Breast Cancer Diagnostics Global Market to 2028 - by Product, Type, Application, End-use and Region

      Research and Markets Logo

      News provided by

      Research and Markets

      Sep 16, 2021, 16:45 ET

      Share this article

      Share this article


      DUBLIN, Sept. 16, 2021 /PRNewswire/ -- The "Global Breast Cancer Diagnostics Market Size, Share & Trends Analysis Report by Product (Platform-based, Instrument-based), by Type (Imaging, Biopsy, Genomic Tests, Blood Tests), by Application, by End-use, by Region, and Segment Forecasts, 2021-2028" report has been added to ResearchAndMarkets.com's offering.

      The global breast cancer diagnostics market size is expected to reach USD 6.8 billion by 2028. The market is expected to expand at a CAGR of 7.0% from 2021 to 2028.

      The introduction of 3D mammography or digital breast tomosynthesis, which is more accurate than 2D mammography, supports market growth. This advanced technology can detect 40.0% more cancers than 2D mammograms and reduce patient recalls. Rapid technological advancements are a major factor expected to drive the market over the coming years.

      Companies are adopting strategies that allow them to use their resources to aid in the development of new products, as well as enhance their supply chain. In November 2019, Exact Sciences Corporation announced the acquisition of Genomic Health, which was expected to help enhance the company's market position and offerings by acquiring its product portfolio. In January 2021, Hologic Inc. announced that it has agreed to acquire Biotheranostics for approximately US$ 230 million. Biotheranostics is a commercial-stage molecular diagnostics provider for breast and metastatic cancers.

      The increasing launch of predictive and companion diagnostic tests for breast cancer is expected to boost the market growth. Recent launches in the segment include BRACAnalysis CDx by Myriad Genetics, which received FDA approval in 2018 as breast cancer companion diagnostics. In May 2019, QIAGEN introduced therascreen PIK3CA RGQ PCR Kit as a companion diagnostic for Novartis proprietary PIQRAY in guiding treatment decisions from tissue and liquid biopsy.

      In January 2019, the Fujifilm Holdings Corporation introduced its Tomosynthesis Biopsy option for ASPIRE Cristalle mammography system. This technique was expected to enable physicians to detect breast cancers more efficiently compared to others by providing an enhanced 3D image and a digital mammogram.

      However, there are specific risk factors associated with these imaging procedures. They involve administering high doses of fluorescent and barium contrast agents, as well as radiation exposure in the case of imaging and endoscopic procedures, which can cause several adverse effects such as nausea or diarrhea. The risks of ionizing radiation exposure associated with the use of CT, MRI, and X-rays, as well as the use of radioactive tracer injections in PET can limit the adoption of such screening procedures. Therefore, factors such as adverse effects of imaging act as a challenge for the companies in this market.

      Breast Cancer Diagnostics Market Report Highlights

      • The imaging segment held the largest revenue share in 2020 and the blood tests segment is expected to grow at the fastest rate
      • By product, the instrument-based products segment accounted for the largest revenue share in 2020 due to government initiatives such as mandatory screening in developed countries such as the U.S., Canada, and the U.K. for women above 45 years of age, increasing the overall testing and screening of breast cancer
      • The platform-based products segment is expected to witness the fastest growth over the forecast period. These tests are mostly used for assessing the efficacy of chemotherapy and targeted therapy in women
      • By application, the diagnostic and predictive segment dominated the market in 2020 and the prognostic segment is expected to witness the fastest CAGR over the forecast period due to increasing collaborations and efforts for advancements in diagnostics
      • The hospitals and clinics segment dominated the market in 2020
      • The medical labs and diagnostics centers segment is expected to witness the fastest CAGR over the forecast period due to an increase in platform-based testing such as NGS, and PCR

      Key Topics Covered:

      Chapter 1 Methodology and Scope

      Chapter 2 Executive Summary

      Chapter 3 Market Variables, Trends & Scope
      3.1 Parent Market Outlook
      3.2 Penetration & Growth Prospect Mapping
      3.3 Regulatory and Reimbursement Framework
      3.4 Market Dynamics
      3.4.1 Market Driver Analysis
      3.4.1.1 Increasing Incidence Of Breast Cancer
      3.4.1.2 Technological Advancements
      3.4.1.3 Favorable Reimbursement Framework For Breast Cancer Diagnosis
      3.4.1.4 Early Detection And Increase In Awareness About Breast Cancer
      3.4.2 Market Restraint Analysis
      3.4.2.1 Adverse Effects Of Screening Procedures
      3.5 Breast Cancer Diagnostics Market Analysis Tools
      3.5.1 Pestel Analysis
      3.5.2 Industry Analysis - Porter's

      Chapter 4 Breast Cancer Diagnostics Market: Type Segment Analysis
      4.1 Breast Cancer Diagnostics Market: Type Movement Analysis
      4.2 Imaging
      4.2.1 Imaging market, 2017 - 2028 (USD Million)
      4.3 Biopsy
      4.3.1 Biopsy market, 2017 - 2028 (USD Million)
      4.4 Genomic Tests
      4.4.1 Genomic tests market, 2017 - 2028 (USD Million)
      4.5 Blood Tests
      4.5.1 Blood tests market, 2017 - 2028 (USD Million)
      4.6 Others
      4.6.1 Others market, 2017 - 2028 (USD Million)

      Chapter 5 Breast Cancer Diagnostics Market: Product Segment Analysis
      5.1 Breast Cancer Diagnostics Market: Product Movement Analysis
      5.2 Platform-based Products
      5.2.1 Platform based products market, 2017 - 2028 (USD Million)
      5.2.2 Next-generation sequencing
      5.2.2.1 Next-Generation Sequencing market, 2017 - 2028 (USD Million)
      5.2.3 Microarrays
      5.2.3.1 Microarrays market, 2017 - 2028 (USD Million)
      5.2.4 PCR
      5.2.4.1 PCR market, 2017 - 2028 (USD Million)
      5.2.5 Others
      5.2.5.1 Others market, 2017 - 2028 (USD Million)
      5.3 Instrument-based Products
      5.3.1 Instrument-based products market, 2017 - 2028 (USD Million)
      5.3.2 Imaging
      5.3.2.1 Imaging market, 2017 - 2028 (USD Million)
      5.3.3 Biopsy
      5.3.3.1 Biopsy market, 2017 - 2028 (USD Million)

      Chapter 6 Breast Cancer Diagnostics Market: Application Segment Analysis
      6.1 Breast Cancer Diagnostics Market: Application Movement Analysis
      6.2 Screening
      6.2.1 Screening market, 2017 - 2028 (USD Million)
      6.3 Diagnostic & Predictive
      6.3.1 Diagnostic and predictive market, 2017 - 2028 (USD Million)
      6.4 Prognostic
      6.4.1 Prognostic market, 2017 - 2028 (USD Million)
      6.5 Research
      6.5.1 Research market, 2017 - 2028 (USD Million)

      Chapter 7 Breast Cancer Diagnostics Market: End-use Segment Analysis
      7.1 Breast Cancer Diagnostics Market: End-use Movement Analysis
      7.2 Hospitals & Clinics
      7.2.1 Hospitals & clinics market, 2017-2028 (USD Million)
      7.3 Diagnostic Centers and Medical Laboratories
      7.3.1 Diagnostic centers and medical laboratories market, 2017-2028 (USD Million)
      7.4 Others
      7.4.1 Others market, 2017-2028 (USD Million)

      Chapter 8 Breast Cancer Diagnostics Market: Segment Analysis, By Region, 2017-2028 (USD Million)

      Chapter 9 Breast Cancer Diagnostics Market: Competitive Analysis
      9.1 Recent developments and impact analysis, by key market participants
      9.1.1 Ansoff Matrix
      9.2 Company Categorization
      9.2.1 Innovators
      9.2.2 Market Leaders
      9.3 Vendor Landscape
      9.3.1 List Of Key Distributors And Channel Partners
      9.3.2 Key Customers
      9.3.3 Key Company Market Share Analysis, 2020
      9.4 Public Companies
      9.4.1 Company Market Position Analysis
      9.4.2 Competitive Dashboard Analysis
      9.4.2.1 Market Differentiators
      9.5 Private Companies
      9.5.1 List Of Key Emerging Companies
      9.6 Major Deals and Strategic Alliances Analysis
      9.6.1 New Product Launches
      9.6.2 Joint Ventures
      9.6.3 Acquisitions
      9.6.4 Licensing And Partnerships
      9.6.5 Conferences And Campaigns
      9.7 Company Profiles
      9.7.1 KONINKLIJKE PHILIPS N.V.
      9.7.1.1 Company overview
      9.7.1.2 Financial performance
      9.7.1.3 Product benchmarking
      9.7.1.4 Strategic initiatives
      9.7.2 DANAHER CORPORATION
      9.7.2.1 Company overview
      9.7.2.2 Financial performance
      9.7.2.3 Product benchmarking
      9.7.2.4 Strategic initiatives
      9.7.3 HOLOGIC INC
      9.7.3.1 Company overview
      9.7.3.2 Financial performance
      9.7.3.3 Product benchmarking
      9.7.3.4 Strategic initiatives
      9.7.4 BECTON, DICKINSON AND COMPANY
      9.7.4.1 Company overview
      9.7.4.2 Financial performance
      9.7.4.3 Product benchmarking
      9.7.4.4 Strategic initiatives
      9.7.5 QIAGEN
      9.7.5.1 Company overview
      9.7.5.2 Financial performance
      9.7.5.3 Product benchmarking
      9.7.5.4 Strategic initiatives
      9.7.6 THERMO FISHER SCIENTIFIC, INC.
      9.7.6.1 Company overview
      9.7.6.2 Financial performance
      9.7.6.3 Product benchmarking
      9.7.6.4 Strategic initiatives
      9.7.7 GENOMIC HEALTH (EXACT SCIENCES)
      9.7.7.1 Company overview
      9.7.7.2 Financial performance
      9.7.7.3 Product benchmarking
      9.7.7.4 Strategic initiatives
      9.7.8 MYRIAD GENETICS, INC.
      9.7.8.1 Company overview
      9.7.8.2 Financial performance
      9.7.8.3 Product benchmarking
      9.7.8.4 Strategic initiatives
      9.7.9 ARGON MEDICAL DEVICES INC.
      9.7.9.1 Company overview
      9.7.9.2 Product benchmarking
      9.7.9.3 Strategic initiatives
      9.7.10 F. HOFFMANN-LA ROCHE LTD
      9.7.10.1 Company overview
      9.7.10.2 Financial performance
      9.7.10.3 Product benchmarking
      9.7.10.4 Strategic initiatives

      For more information about this report visit https://www.researchandmarkets.com/r/p6ntfy

      Media Contact:

      Research and Markets
      Laura Wood, Senior Manager
      [email protected]   

      For E.S.T Office Hours Call +1-917-300-0470
      For U.S./CAN Toll Free Call +1-800-526-8630
      For GMT Office Hours Call +353-1-416-8900

      U.S. Fax: 646-607-1904
      Fax (outside U.S.): +353-1-481-1716

      SOURCE Research and Markets

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.